FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256604417> ?p ?o ?g. }

• W4256604417 endingPage "S91" @default.
• W4256604417 startingPage "S91.3" @default.
• W4256604417 abstract "<h3></h3> Everolimus was developed for use with cyclosporine as a new immunosuppressant in the prevention of rejection in transplant patients. It binds to FK binding protein and modulates the activities of the mammalian Target of Rapamycin following entry into cytoplasm. A reliable and accurate measurement of everolimus blood concentrations is vital in kidney transplant patients. The purpose of this study was to test for the potential cross-reactivities of the major hydroxylated everolimus metabolites with the immunoassay developed to measure everolimus in the blood of transplant patients. Everolimus is primarily metabolized by the cytochrome P4503A enzymes of the liver and small intestine. The major everolimus metabolites in the blood of kidney transplant patients (n=133 samples) have been identified as 45/46-hydroxy, 24-hydroxy, and 25-hydroxy everolimus. To test the cross-reactivity of the three major metabolites, everolimus was incubated with human liver microsomes for 15 minutes in vitro, which resulted in the formation of 9 hydroxylated metabolites. The metabolites of interest, 45/46-hydroxy, 24-hydroxy, and 25-hydroxy everolimus, were identified by Mass Spectrometry (MS)-ion trap MS/MS analysis and the blood samples from kidney graft patients were extracted and run under the same chromatographic conditions. Comparison of the MS/MS spectra from metabolites from patient blood samples with the metabolites from human liver microsome incubations in vitro, confirmed that the structures of the major hydroxy everolimus metabolites in blood were identical to those produced in vitro. An HPLC/UV assay was used to isolate the hydroxy metabolites, and the metabolite purities were confirmed by HPLC/UV and LC/MS analysis, which indicated that the metabolites were ≥99% free of other everolimus derivatives, and most importantly, none of the samples contained detectable amounts of everolimus (lower limit of detection of LC/MS assay: 0.1 ng/mL). The three metabolites were separately spiked in blood and prepared for further for cross-reactivity testing with a clinical immunoassay. 3-hydroxy everolimus metabolites present in blood of kidney transplant patients were produced and isolated in vitro with sufficient purity and quantity for cross reactivity testing with clinical immunoassay. In conclusion, we have established a reliable and accurate assay for everolimus. Furthermore, this study indicates that everolimus has a narrow therapeutic range and requires close therapeutic drug monitoring for optimal immunosuppression in transplant patients." @default.
• W4256604417 created "2022-05-12" @default.
• W4256604417 creator A5018641892 @default.
• W4256604417 creator A5056068561 @default.
• W4256604417 creator A5086612257 @default.
• W4256604417 date "2005-01-01" @default.
• W4256604417 modified "2023-09-30" @default.
• W4256604417 title "79 IMMUNOASSAY CROSS-REACTIVITY TESTING OF THE MAJOR EVEROLIMUS METABOLITES IN THE BLOOD OF KIDNEY TRANSPLANT PATIENTS" @default.
• W4256604417 doi "https://doi.org/10.2310/6650.2005.00005.78" @default.
• W4256604417 hasPublicationYear "2005" @default.
• W4256604417 type Work @default.
• W4256604417 citedByCount "0" @default.
• W4256604417 crossrefType "journal-article" @default.
• W4256604417 hasAuthorship W4256604417A5018641892 @default.
• W4256604417 hasAuthorship W4256604417A5056068561 @default.
• W4256604417 hasAuthorship W4256604417A5086612257 @default.
• W4256604417 hasConcept C112705442 @default.
• W4256604417 hasConcept C126322002 @default.
• W4256604417 hasConcept C159654299 @default.
• W4256604417 hasConcept C1621761 @default.
• W4256604417 hasConcept C185592680 @default.
• W4256604417 hasConcept C202751555 @default.
• W4256604417 hasConcept C203014093 @default.
• W4256604417 hasConcept C2777477808 @default.
• W4256604417 hasConcept C2779699572 @default.
• W4256604417 hasConcept C2780091579 @default.
• W4256604417 hasConcept C2780272996 @default.
• W4256604417 hasConcept C2780303639 @default.
• W4256604417 hasConcept C2780420688 @default.
• W4256604417 hasConcept C55493867 @default.
• W4256604417 hasConcept C71924100 @default.
• W4256604417 hasConcept C87644729 @default.
• W4256604417 hasConcept C98274493 @default.
• W4256604417 hasConceptScore W4256604417C112705442 @default.
• W4256604417 hasConceptScore W4256604417C126322002 @default.
• W4256604417 hasConceptScore W4256604417C159654299 @default.
• W4256604417 hasConceptScore W4256604417C1621761 @default.
• W4256604417 hasConceptScore W4256604417C185592680 @default.
• W4256604417 hasConceptScore W4256604417C202751555 @default.
• W4256604417 hasConceptScore W4256604417C203014093 @default.
• W4256604417 hasConceptScore W4256604417C2777477808 @default.
• W4256604417 hasConceptScore W4256604417C2779699572 @default.
• W4256604417 hasConceptScore W4256604417C2780091579 @default.
• W4256604417 hasConceptScore W4256604417C2780272996 @default.
• W4256604417 hasConceptScore W4256604417C2780303639 @default.
• W4256604417 hasConceptScore W4256604417C2780420688 @default.
• W4256604417 hasConceptScore W4256604417C55493867 @default.
• W4256604417 hasConceptScore W4256604417C71924100 @default.
• W4256604417 hasConceptScore W4256604417C87644729 @default.
• W4256604417 hasConceptScore W4256604417C98274493 @default.
• W4256604417 hasIssue "1" @default.
• W4256604417 hasLocation W42566044171 @default.
• W4256604417 hasOpenAccess W4256604417 @default.
• W4256604417 hasPrimaryLocation W42566044171 @default.
• W4256604417 hasRelatedWork W1492229869 @default.
• W4256604417 hasRelatedWork W1558880863 @default.
• W4256604417 hasRelatedWork W1982989998 @default.
• W4256604417 hasRelatedWork W1998356222 @default.
• W4256604417 hasRelatedWork W2009612970 @default.
• W4256604417 hasRelatedWork W2056938528 @default.
• W4256604417 hasRelatedWork W2076055768 @default.
• W4256604417 hasRelatedWork W2088748089 @default.
• W4256604417 hasRelatedWork W2094073838 @default.
• W4256604417 hasRelatedWork W2132691174 @default.
• W4256604417 hasVolume "53" @default.
• W4256604417 isParatext "false" @default.
• W4256604417 isRetracted "false" @default.
• W4256604417 workType "article" @default.